함께 비교하는 진짜 ADC · Antibody · CGT 데이터

ADCBiologicstaleAstraZenecaPhase 2

AZD9574 (AZD9574)

Advanced Solid Malignancies · Ovarian Cancer

#OvarianCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

ADCBiologicstaleHansoh BioMedical R&D CompanyPhase 1

HS-20089 (HS-20089)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

AntibodystaleAravive, Inc.Phase 2

Batiraxcept (Batiraxcept)

Clear Cell Renal Cell Carcinoma · Clear Cell Renal Cell Carcinoma

#ClearCellRenalCellCarcinoma#Antibody#Phase2#항체#면역항체+2

효능 ORR 11%임상시험 5상태 DISCONTINUED

ADCBiologicstaleSeagen Inc.Phase 2

ladiratuzumab vedotin (ladiratuzumab vedotin)

HER2 Positive Breast Neoplasms; Hormone Receptor Positive Breast Neoplasms · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

효능 ORR 34%임상시험 5상태 ACTIVE

CGTBiologicstaleiCell Gene TherapeuticsPhase 1

BCMA-CD19 cCAR T cells (BCMA-CD19 cCAR T cells)

Relapsed/Refractory, Systemic Lupus Erythematosus (SLE) · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+5

AntibodystaleEisai Inc.Phase 2

Farletuzumab ecteribulin (Farletuzumab ecteribulin)

Solid Tumor · Solid Tumor

#SolidTumor#Antibody#Phase2#항체#면역항체+2

효능 ORR 20%임상시험 4상태 RECRUITING

ADCBiologicstaleSeagen Inc.Phase 2

denintuzumab mafodotin (denintuzumab mafodotin)

Lymphoma, B-cell; Lymphoma, Large B-Cell, Diffuse · Lymphoma, B-cell

#LymphomaB-cell#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

임상시험 4상태 DISCONTINUED

CGTBiologicstaleThe Affiliated Hospital of Xuzh…Phase 2

Anti-CD56 CAR T (Anti-CD56 CAR T)

Extranodal NK T Cell Lymphoma; NK-Cell Leukemia · Extranodal NK T Cell Lymphoma

#ExtranodalNKTCellLymphoma#CGT#Phase2#세포유전치료#CAR-T+3

CGTBiologicstaleFrontera TherapeuticsPhase 2

FT-003 (FT-003)

Diabetic Macular Edema · Neovascular Age-related Macular Degenera

#NeovascularAge-relatedMacularDeg#CGT#Phase2#세포유전치료#CAR-T+4

CGTBiologicstaleHebei Senlang Biotechnology Inc…Phase 2

BCMA CAR-T (BCMA CAR-T)

Multiple Myeloma, Newly Diagnosed · BCMA

#BCMA#CGT#Phase2#세포유전치료#CAR-T+4

ADCBiologicstaleSeagen Inc.Phase 1

SGN-CD19A (SGN-CD19A)

Burkitt Lymphoma; Precursor B-cell Lymphoblastic Leukemia-Lymphoma · CD19

#CD19#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3

AntibodystaleEli Lilly and CompanyPhase 2

Icrucumab (Icrucumab)

Colon Cancer; Rectal Cancer · Carcinoma of Urinary Tract

#CarcinomaofUrinaryTract#Antibody#Phase2#항체#면역항체+4

효능 ORR 28.8%임상시험 4상태 ACTIVE

AntibodystaleBiogenPhase 2

Natalizumab (Natalizumab)

Crohn's Disease · Multiple Sclerosis, Relapsing-Remitting

#MultipleSclerosisRelapsing-Remit#Antibody#Phase2#항체#면역항체+3

효능 ORR 52%임상시험 4상태 ACTIVE

AntibodystaleHoffmann-La RochePhase 2

Rituxumab (Rituxumab)

B-cell Non-Hodgkin Lymphoma · B-cell Non-Hodgkin Lymphoma

#B-cellNon-HodgkinLymphoma#Antibody#Phase2#항체#면역항체+2

효능 ORR 95%임상시험 4상태 ACTIVE

ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

MK-3120 (MK-3120)

Bladder Cancer · Bladder Cancer

#BladderCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

CGTBiologicstaleYake Biotechnology Ltd.Phase 1

APRIL CAR-T cells (APRIL CAR-T cells)

Multiple Myeloma in Relapse; Multiple Myeloma, Refractory · FRα

#FR#CGT#Phase1#세포유전치료#CAR-T+5

CGTBiologicstaleBeijing BiotechPhase 2

DLL3-CAR-NK cells (DLL3-CAR-NK cells)

Extensive Stage Lung Small Cell Cancer · SCLC, Extensive Stage

#SCLCExtensiveStage#CGT#Phase2#세포유전치료#CAR-T+3

AntibodystaleBeiGenePhase 1

atezolizumab (Tecentriq, Tislelizumab，atezolizumab or sugemalimab)

NSCLC · NSCLC

#NSCLC#Antibody#Phase1#항체#면역항체+2

CGTBiologicstaleSara V. LatorrePhase 2

ARI-0001 cells (ARI-0001 cells)

Acute Lymphoid Leukemia · Acute Lymphoid Leukemia

#AcuteLymphoidLeukemia#CGT#Phase2#세포유전치료#CAR-T+3

CGTBiologicstaleElvira UmyarovaPhase 1

Universal Donor Expanded TGF-beta-imprinted NK Cells (Universal Donor Expanded TGF-beta-imprinted NK Cells)

Recurrent Multiple Myeloma; Refractory Multiple Myeloma · HER2

#HER2#CGT#Phase1#세포유전치료#CAR-T+4

ADCBiologicstaleMerck Sharp & Dohme LLCPhase 2

5-hydroxytryptamine subtype 3 receptor antagonist (5-hydroxytryptamine subtype 3 receptor antagonist)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3

CGTBiologicstaleChongqing Precision Biotech Co.…Phase 2

CD123 targeted CAR-NK cells (CD123 targeted CAR-NK cells)

Acute Myeloid Leukemia; Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) · FRα

#FR#CGT#Phase2#세포유전치료#CAR-T+4

CGTBiologicstaleAllife Medical Science and Tech…Phase 1

pd-1 and DC-NK cells (pd-1 and DC-NK cells)

Solid Tumor · PD-1

#PD-1#CGT#Phase1#세포유전치료#CAR-T+3

ADCBiologicstaleHoffmann-La RochePhase 2

Belvarafenib (Belvarafenib)

Solid Tumors · Solid Tumors

#SolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1